Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.7 USD | -1.62% | -4.19% | -27.74% |
May. 14 | Transcript : Sanara MedTech Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 13 | Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down | MT |
Financials (USD)
Sales 2024 * | 78M | Sales 2025 * | - | Capitalization | 256M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 4M | EV / Sales 2024 * | 3.28 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-135
x | P/E ratio 2025 * |
53
x | Employees | 108 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.95% |
Latest transcript on Sanara MedTech Inc.
1 day | -1.62% | ||
1 week | -4.19% | ||
1 month | -6.72% | ||
3 months | -21.92% | ||
6 months | -8.33% | ||
Current year | -27.74% |
Managers | Title | Age | Since |
---|---|---|---|
Michael McNeil
DFI | Director of Finance/CFO | 59 | 18-04-10 |
Chief Tech/Sci/R&D Officer | - | 22-12-31 | |
Chief Tech/Sci/R&D Officer | 39 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Tanzberger
BRD | Director/Board Member | 55 | 21-12-31 |
Roszell Mack
BRD | Director/Board Member | 57 | 21-12-31 |
Eric Major
BRD | Director/Board Member | 55 | 23-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 29.7 | -1.62% | 9,259 |
24-05-30 | 30.19 | -1.66% | 26,336 |
24-05-29 | 30.7 | +0.56% | 23,648 |
24-05-28 | 30.53 | -1.52% | 11,958 |
24-05-24 | 31 | +7.64% | 23,444 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.74% | 256M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- SMTI Stock